Oligopeptide having proinflammatory cytokine secretion-inhibiting activity
AssigneeOsaka University
InventorsMunehisa Shimamura, Hironori Nakagami, Hitomi Kurinami, Ryuichi Morishita
Life of this patent
Estimating the term…
Abstract
Provided is an oligopeptide having preventive and therapeutic effects on infarction diseases. The oligopeptide contains a DE loop sequence of RANKL protein, and has inhibitory activity on proinflammatory cytokine secretion from cells.
Claims8
An oligopeptide having inhibitory activity on proinflammatory cytokine secretion from cells, the oligopeptide containing a DE loop sequence of RANKL protein, a β-strand D sequence of RANKL protein adjacent to the N-terminal side of the DE loop sequence, and a β-strand E sequence of RANKL protein adjacent to the C-terminal side of the DE loop sequence,
- wherein the oligopeptide is free of a CD loop sequence of RANKL protein, the DE loop sequence has the amino acid sequence of SEQ ID NO:
- 1, the β-strand D sequence has the amino acid sequence of any one of SEQ ID NOs:
- 2 to 5, the β-strand E sequence has the amino acid sequence of any one of SEQ ID NOs:
- 6 to 9, and the length of the oligopeptide is no more than 50 amino acid residues.
Dependencies are inferred from the claim text.